GlassScriptPhysician profile
Bryden Thomas Considine
NPI 1356760839
$497.96
in general payments reported to CMS, 2019-2025
9 companies · $14.18 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $101 · 2023: $30.34 · 2024: $153 · 2025: $14.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163 · Education: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $162.85 |
| Education | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $99.95 | 2021 | |
| Seagen INC. | $99.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $74.93 | 2024 | Libtayo |
| Janssen Scientific Affairs, LLC | $73.74 | 2023-2024 | Erleada |
| Pharmacyclics LLC, An Abbvie Company | $47.82 | 2022 | |
| Aveo Pharmaceuticals, INC. | $35.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $29.34 | 2022 | |
| Tg Therapeutics, INC. | $24.00 | 2022 | |
| Mimedx Group, INC. | $14.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryden Considine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.